EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pleurotus eryngii Mushrooms Fermented with Human Fecal Microbiota Protect Intestinal Barrier Integrity: Immune Modulation and Signalling Pathways Counter Deoxycholic Acid-Induced Disruption in Healthy Colonic Tissue

Evangelia N Kerezoudi iD, Georgios I Zervakis iD, Vasiliki Pletsa iD, Adamantini Kyriacou iD, Robert J Brummer iD, Ignacio Rangel iD

Nutrients · 2025

DOI: 10.3390/nu17040694 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Evangelia N Kerezoudi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nutrition-Gut-Brain Interactions Research Centre, School of Medical Sciences, Örebro University, 70182 Örebro, Sweden. Hauptthemen laut MEDLINE: Deoxycholic Acid, Gastrointestinal Microbiome, Pleurotus, Intestinal Mucosa. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was co-funded by the EU and Greek national funds, through the Operational Program Competitiveness, Entrepreneurship and Innovation under the call…, EU and Greek national funds, through the Operational Program Competitiveness, Entrepreneurship and Innovation under the call RESEARCH-CREATE-INNOVATE.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study explores the potential of the Pleurotus eryngii mushroom fermentation supernatant (FS-PEWS) as an intervention for mitigating sodium deoxycholate (SDC)-induced intestinal barrier dysfunction and inflammation.

Methods

FS-PEWS was assessed for its protective effects against SDC-induced barrier dysfunction and inflammation using an in vitro Caco-2 cell model and ex vivo colonic biopsies from healthy adult donors, where barrier integrity, permeability, immunomodulation and receptor-mediated pathways were evaluated.

Results

In Caco-2 cells, SDC exposure downregulated ZO-1, occludin, and claudin-1 expression, with FS-PEWS restoring ZO-1 and claudin-1 levels while maintaining cell viability. In colonic biopsies from healthy adults, FS-PEWS maintained tissue integrity and selectively mitigated transcellular permeability without affecting paracellular permeability when combined with the stressor. Additionally, FS-PEWS exhibited potent anti-inflammatory effects, reducing pro-inflammatory cytokines, e.g., TNF-α, IL-6, and IL-1β and modulating receptor-mediated pathways, i.e., TLR-4, dectin-1.

Conclusions

These results demonstrate the potential of FS-PEWS to sustain intestinal barrier function and modulate immune responses under stress, highlighting its therapeutic potential for managing gut barrier dysfunction and inflammation associated with microbial metabolite-induced disruptions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deoxycholic AcidGastrointestinal MicrobiomePleurotusIntestinal MucosaColonFecesHumansCaco-2 CellsFermentationSignal TransductionPermeabilityAdultCytokinesMaleFemaleImmunomodulationInflammationZonula Occludens-1 Protein

Stichwörter der Autor:innen

Pleurotus eryngii mushroomsUssing chambercytokinesdeoxycholic bile acidgut barriersignalling pathway

Substanzen

Deoxycholic AcidCytokinesZonula Occludens-1 Protein

Autor:innen und Institutionen

  • Nutrition-Gut-Brain Interactions Research Centre, School of Medical Sciences, Örebro University, 70182 Örebro, Sweden.
  • Department of Nutrition and Dietetics, Harokopio University, 17676 Athens, Greece.
  • Laboratory of General and Agricultural Microbiology, Department of Crop Science, Agricultural University of Athens, 11855 Athens, Greece.
  • Institute of Chemical Biology, National Hellenic Research Foundation, 11635 Athens, Greece.

ORCID-Profile: Evangelia N Kerezoudi, Georgios I Zervakis, Vasiliki Pletsa, Adamantini Kyriacou, Robert J Brummer, Ignacio Rangel

Förderung

  • This research was co-funded by the EU and Greek national funds, through the Operational Program Competitiveness, Entrepreneurship and Innovation under the call…
  • EU and Greek national funds, through the Operational Program Competitiveness, Entrepreneurship and Innovation under the call RESEARCH-CREATE-INNOVATE

Zitieren

APA

Kerezoudi, E. N., Zervakis, G. I., Pletsa, V., Kyriacou, A., Brummer, R. J., & Rangel, I. (2025). Pleurotus eryngii Mushrooms Fermented with Human Fecal Microbiota Protect Intestinal Barrier Integrity: Immune Modulation and Signalling Pathways Counter Deoxycholic Acid-Induced Disruption in Healthy Colonic Tissue. Nutrients. https://doi.org/10.3390/nu17040694

Vancouver

Kerezoudi EN, Zervakis GI, Pletsa V, Kyriacou A, Brummer RJ, Rangel I. Pleurotus eryngii Mushrooms Fermented with Human Fecal Microbiota Protect Intestinal Barrier Integrity: Immune Modulation and Signalling Pathways Counter Deoxycholic Acid-Induced Disruption in Healthy Colonic Tissue. Nutrients. 2025. doi:10.3390/nu17040694

BibTeX
@article{Kerezoudi2025,
  author = {Kerezoudi, Evangelia N and Zervakis, Georgios I and Pletsa, Vasiliki and Kyriacou, Adamantini and Brummer, Robert J and Rangel, Ignacio},
  title = {Pleurotus eryngii Mushrooms Fermented with Human Fecal Microbiota Protect Intestinal Barrier Integrity: Immune Modulation and Signalling Pathways Counter Deoxycholic Acid-Induced Disruption in Healthy Colonic Tissue},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17040694}
}
Kostenlos starten →